State of Wisconsin Investment Board
STOK icon

State of Wisconsin Investment Board’s Stoke Therapeutics STOK Stock Holding History

State of Wisconsin Investment Board’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
47,859
+33,040
+223% +$1.08M ﹤0.01% 1509
2025
Q4 		$470K Buy
+14,819
New +$445K ﹤0.01% 1980
2025
Q3 		– Sell
-34,798
Closed -$395K – 2518
2025
Q2 		$395K Sell
34,798
-2,808
-7% -$26.7K ﹤0.01% 1960
2025
Q1 		$250K Buy
37,606
+5,890
+19% +$54.9K ﹤0.01% 2038
2024
Q4 		$350K Sell
31,716
-7,398
-19% -$90.9K ﹤0.01% 1956
2024
Q3 		$481K Sell
39,114
-1,488
-4% -$21.1K ﹤0.01% 1890
2024
Q2 		$549K Sell
40,602
-7,598
-16% -$103K ﹤0.01% 1780
2024
Q1 		$651K Sell
48,200
-38,400
-44% -$233K ﹤0.01% 1613
2023
Q4 		$456K Buy
86,600
+7,076
+9% +$30.2K ﹤0.01% 1801
2023
Q3 		$313K Sell
79,524
-7,347
-8% -$48.3K ﹤0.01% 2035
2023
Q2 		$923K Buy
86,871
+18,676
+27% +$199K ﹤0.01% 1484
2023
Q1 		$568K Buy
68,195
+23,850
+54% +$215K ﹤0.01% 1814
2022
Q4 		$409K Buy
44,345
+29,115
+191% +$303K ﹤0.01% 1980
2022
Q3 		$196K Buy
15,230
+971
+7% +$15.5K ﹤0.01% 2411
2022
Q2 		$188K Sell
14,259
-25,741
-64% -$391K ﹤0.01% 2512
2022
Q1 		$842K Buy
40,000
+22,700
+131% +$455K ﹤0.01% 1675
2021
Q4 		$415K Hold
17,300
– – ﹤0.01% 1738
2021
Q3 		$440K Hold
17,300
– – ﹤0.01% 1729
2021
Q2 		$582K Hold
17,300
– – ﹤0.01% 1642
2021
Q1 		$672K Hold
17,300
– – ﹤0.01% 1484
2020
Q4 		$1.07M Sell
17,300
-2,200
-11% -$101K ﹤0.01% 1313
2020
Q3 		$653K Hold
19,500
– – ﹤0.01% 1398
2020
Q2 		$465K Buy
19,500
+5,400
+38% +$128K ﹤0.01% 1456
2020
Q1 		$323K Buy
14,100
+200
+1% +$4.94K ﹤0.01% 1476
2019
Q4 		$394K Hold
13,900
– – ﹤0.01% 1500
2019
Q3 		$299K Buy
+13,900
New +$388K ﹤0.01% 1449

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State of Wisconsin Investment Board's STOK Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Stoke Therapeutics (STOK) stake by 223% in Q1 2026, buying an estimated $1.08M and bringing the position to 47,859 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

State of Wisconsin Investment Board first reported a position in STOK in Q3 2019 and has held it in 26 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • State of Wisconsin Investment Board held 47,859 shares of Stoke Therapeutics worth $1.56M as of Q1 2026.
  • State of Wisconsin Investment Board bought 33,040 Stoke Therapeutics shares in Q1 2026, an estimated $1.08M.
  • Stoke Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1509 holding.
  • State of Wisconsin Investment Board first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 26 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.